ROSSI, GIOVANNA
 Distribuzione geografica
Continente #
AS - Asia 183
EU - Europa 74
NA - Nord America 47
SA - Sud America 38
AF - Africa 1
Totale 343
Nazione #
HK - Hong Kong 83
US - Stati Uniti d'America 47
CN - Cina 36
BR - Brasile 32
SG - Singapore 31
FR - Francia 17
IT - Italia 16
DE - Germania 13
IN - India 13
AT - Austria 9
NL - Olanda 8
JP - Giappone 6
GB - Regno Unito 4
ID - Indonesia 4
EC - Ecuador 3
VE - Venezuela 3
IQ - Iraq 2
SA - Arabia Saudita 2
UA - Ucraina 2
BD - Bangladesh 1
FI - Finlandia 1
IE - Irlanda 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
PL - Polonia 1
SE - Svezia 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 343
Città #
Hong Kong 61
Singapore 12
Bengaluru 10
Beijing 9
Cangzhou 9
Frankfurt am Main 9
Council Bluffs 8
Chicago 6
Vienna 6
Shanghai 5
Jakarta 4
Milan 4
São Paulo 4
Tokyo 4
Ashburn 3
Caracas 3
Los Angeles 3
Nuremberg 3
Rho 3
Amsterdam 2
Bexley 2
Fremont 2
Quito 2
Rio de Janeiro 2
Roubaix 2
Salt Lake City 2
Selvazzano Dentro 2
Tampa 2
Tokushima 2
Vicenza 2
Afonso Cláudio 1
Almaty 1
Ariquemes 1
Baghdad 1
Belo Horizonte 1
Brasília 1
Brescia 1
Brooklyn 1
Cubatão 1
Cuiabá 1
Dakar 1
Dammam 1
Duque de Caxias 1
Düsseldorf 1
Elk Grove Village 1
Erode 1
Eugenópolis 1
Evanston 1
Florianópolis 1
Gazipur 1
Guangzhou 1
Guayaquil 1
Hortolândia 1
Ibicoara 1
Imperatriz 1
Itapecerica da Serra 1
Jaraguá 1
Kochi 1
Kuala Lumpur 1
Lake Elsinore 1
Lappeenranta 1
Las Vegas 1
Maringá 1
Marília 1
Mosul 1
Naas 1
Nerópolis 1
New Delhi 1
Newark 1
Nova Olinda 1
Novo Lino 1
Padova 1
Phoenix 1
Plain City 1
Poplar 1
Portsmouth 1
Queens 1
Riga 1
Riyadh 1
Salvador 1
San Jose 1
Santana de Parnaíba 1
Seoul 1
Sete Lagoas 1
Silver Spring 1
Tashkent 1
Tramandaí 1
Turin 1
Valente 1
Valinhos 1
Valparaíso de Goiás 1
Wilmington 1
Totale 250
Nome #
“Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.” 48
Clinical research in cancer palliative care: a metaresearch analysis 35
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research 29
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force 27
Detection and characterization of circulating tumor associated cells in metastatic breast cancer 23
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study 21
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 21
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study 21
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis 21
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 17
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer 15
Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer 15
Clinical applications of circulating tumor DNA 15
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 14
Cell-free DNA and circulating tumor cells: Comprehensive liquid biopsy analysis in advanced breast cancer 12
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer 11
Developmental therapeutics for inflammatory breast cancer: Biology and translational directions 11
Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients 10
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer 10
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer 10
Promises and pitfalls of using liquid biopsy for precision medicine 10
Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer 9
Detection of activating estrogen receptor gene (ESR1) mutations in single circulating tumor cells 9
Totale 414
Categoria #
all - tutte 1.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025414 0 0 0 0 43 11 26 23 27 55 74 155
Totale 414